Xiaowen specialises in M&A transactions and corporate law structuring of national and international companies. She has particular expertise in the area of corporate transactions and structuring in the healthcare sector, is familiar with the specifics of the highly regulated healthcare sector and has excellent networks there.

 

Of particular note are the approximately 60 M&A transactions for the creation of medical care centre groups as well as nine clinic transactions which underline her successful track record for ongoing advice to various corporate groups. On the product side, Xiaowen is also an experienced legal adviser with medtech, biotech and pharmaceutical transactions, including digital health investments. As a native Chinese speaker and member of the China Group, Xiaowen also advises Chinese companies and investors on outbound activities in Germany and Europe.

显示完整简历 隐藏完整简历

最新新闻和观点

公司/并购与资本市场

Advising Thought Machine on its $160 million Series D funding round

2022年5月18日

作者

点击此处了解更多
酒店与休闲

Electronic instructions for use of medical devices - Requirements under new Implementing Regulation (EU) 2021/2226

2022年5月18日
In-depth analysis

作者 Irina Rebin

点击此处了解更多
酒店与休闲

Telehealth advertising admissible if accepted professional standards are observed

2022年5月18日
Briefing

作者 Dr. Daniel Tietjen

点击此处了解更多
酒店与休闲

TAMG – the new Veterinary Medicinal Products Act

2022年5月18日
Briefing

作者 Dr. Daniel Tietjen

点击此处了解更多

与我会面: